Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

Wells Fargo's senior analyst sees a short squeeze coming in 2026. He expects HRI, VERA, and MTDR stocks to benefit from its ...

The CBSE Class 12 Biology exam will be held on March 27, 2026. It is normal to feel excited or a little nervous. Biology is ...

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

Macquarie believes that Syngene offers an attractive risk-reward, and expects fundamentals to improve while its valuations ...

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

A 2022 review in the Journal of Food Quality and Health noted that while no health hazards from GMOs have been proven in ...

Trump and Xi have agreed in principle to AI talks. A “smart” security agenda would cut shared risk, not U.S. leverage.

The new year began on a down note for employees of two companies in Wilmington, the continuation of a disturbing trend for ...

An update from Noxopharm Ltd. ( ($AU:NOX) ) is now available. Noxopharm Limited has notified the market of the issue of 520,000 unquoted options, ...